Lucy Burr
Lucy Burr
Mater Health Services
Verified email at
Cited by
Cited by
VX-445–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles
D Keating, G Marigowda, L Burr, C Daines, MA Mall, EF McKone, ...
New england journal of medicine 379 (17), 1612-1620, 2018
A novel microbiota stratification system predicts future exacerbations in bronchiectasis
GB Rogers, NMM Zain, KD Bruce, LD Burr, AC Chen, DW Rivett, ...
Annals of the American Thoracic Society 11 (4), 496-503, 2014
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo …
GB Rogers, KD Bruce, ML Martin, LD Burr, DJ Serisier
The lancet Respiratory medicine 2 (12), 988-996, 2014
Matrix metalloproteinases vary with airway microbiota composition and lung function in non–cystic fibrosis bronchiectasis
SL Taylor, GB Rogers, ACH Chen, LD Burr, MA McGuckin, DJ Serisier
Annals of the American Thoracic Society 12 (5), 701-707, 2015
Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis
KA Ramsey, ACH Chen, G Radicioni, R Lourie, M Martin, A Broomfield, ...
American journal of respiratory and critical care medicine 201 (6), 661-670, 2020
Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease
C Rigauts, J Aizawa, SL Taylor, GB Rogers, M Govaerts, P Cos, L Ostyn, ...
European Respiratory Journal 59 (5), 2022
Oxidative and endoplasmic reticulum stress in respiratory disease
ACH Chen, L Burr, MA McGuckin
Clinical & translational immunology 7 (6), e1019, 2018
Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry
SK Visser, PTP Bye, GJ Fox, LD Burr, AB Chang, CL Holmes-Liew, P King, ...
Respiratory medicine 155, 97-103, 2019
The impact of CFTR modulator therapies on CF airway microbiology
GB Rogers, SL Taylor, LR Hoffman, LD Burr
Journal of Cystic Fibrosis 19 (3), 359-364, 2020
Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut
Y Wang, LEX Leong, RL Keating, T Kanno, GCJ Abell, FM Mobegi, ...
Gut Microbes 10 (3), 367-381, 2019
Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce
JP Vogel, B Tendal, M Giles, C Whitehead, W Burton, S Chakraborty, ...
Australian and New Zealand Journal of Obstetrics and Gynaecology 60 (6), 840-851, 2020
Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non–Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low …
LD Burr, GB Rogers, ACH Chen, BR Hamilton, GF Pool, SL Taylor, ...
Annals of the American Thoracic Society 13 (10), 1697-1703, 2016
FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis
SL Taylor, RJ Woodman, ACH Chen, LD Burr, DL Gordon, MA McGuckin, ...
Thorax 72 (4), 304-310, 2017
Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis
JM Choo, GCJ Abell, R Thomson, L Morgan, G Waterer, DL Gordon, ...
Msphere 3 (2), 10.1128/msphere. 00103-18, 2018
Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma
RB Werder, MA Ullah, MM Rahman, J Simpson, JP Lynch, N Collinson, ...
American Journal of Respiratory and Critical Care Medicine 205 (3), 300-312, 2022
Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation
ACH Chen, ML Martin, R Lourie, GB Rogers, LD Burr, SZ Hasnain, ...
PLoS One 10 (3), e0119325, 2015
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
AZ Uluer, G MacGregor, P Azevedo, V Indihar, C Keating, MA Mall, ...
The Lancet Respiratory Medicine 11 (6), 550-562, 2023
Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samples
GP Scoleri, JM Choo, LEX Leong, TR Goddard, L Shephard, LD Burr, ...
Journal of clinical microbiology 54 (9), 2395-2398, 2016
GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection
CX Foo, S Bartlett, KY Chew, MD Ngo, H Bielefeldt-Ohmann, ...
European Respiratory Journal 61 (3), 2023
Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?
SK Visser, PTP Bye, GJ Fox, LD Burr, AB Chang, CL Holmes-Liew, P King, ...
Lung 197, 803-810, 2019
The system can't perform the operation now. Try again later.
Articles 1–20